DK1161248T3 - Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger - Google Patents

Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger

Info

Publication number
DK1161248T3
DK1161248T3 DK00907851T DK00907851T DK1161248T3 DK 1161248 T3 DK1161248 T3 DK 1161248T3 DK 00907851 T DK00907851 T DK 00907851T DK 00907851 T DK00907851 T DK 00907851T DK 1161248 T3 DK1161248 T3 DK 1161248T3
Authority
DK
Denmark
Prior art keywords
nitrate
acidifying agent
treatment
burns
source
Prior art date
Application number
DK00907851T
Other languages
English (en)
Inventor
Arthur Tudor Tucker
Nigel Benjamin
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Application granted granted Critical
Publication of DK1161248T3 publication Critical patent/DK1161248T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK00907851T 1999-03-09 2000-03-09 Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger DK1161248T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905425.6A GB9905425D0 (en) 1999-03-09 1999-03-09 Pharmaceutical composition
PCT/GB2000/000853 WO2000053193A1 (en) 1999-03-09 2000-03-09 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia

Publications (1)

Publication Number Publication Date
DK1161248T3 true DK1161248T3 (da) 2009-08-31

Family

ID=10849290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00907851T DK1161248T3 (da) 1999-03-09 2000-03-09 Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger

Country Status (11)

Country Link
US (3) US20020090401A1 (da)
EP (1) EP1161248B1 (da)
JP (1) JP5084985B2 (da)
AT (1) ATE430573T1 (da)
AU (1) AU2931500A (da)
DE (1) DE60042153D1 (da)
DK (1) DK1161248T3 (da)
ES (1) ES2326729T3 (da)
GB (1) GB9905425D0 (da)
PT (1) PT1161248E (da)
WO (1) WO2000053193A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180379A1 (en) 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US8066904B2 (en) * 2001-09-05 2011-11-29 Geno Llc Controlled generation of nitric oxide
JP5564157B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 心臓血管状態の処置のための亜硝酸塩の使用方法
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2006023616A2 (en) 2004-08-18 2006-03-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
DK1871433T3 (da) * 2005-03-24 2009-08-10 Nolabs Ab Kosmetisk behandling med nitrogenoxid, anordning til udförelse af denne behandling samt fremstillingsproces dertil
AU2006249323B2 (en) 2005-05-27 2012-08-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
GB0607402D0 (en) 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
WO2009006701A1 (en) * 2007-07-12 2009-01-15 Peter O'gorman Topical medicament
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
CN101939014B (zh) 2007-11-15 2016-04-27 路易斯安那州大学及农业和机械学院管理委员会 亚硝酸盐在慢性缺血中的应用
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
EP2247381B1 (en) 2008-01-28 2016-11-30 Geno LLC Conversion of nitrogen dioxide (no2) to nitric oxide (no)
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
US20110104240A1 (en) * 2008-06-24 2011-05-05 Micropharma Limited Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
US8613958B2 (en) 2009-06-22 2013-12-24 Geno Llc Nitric oxide therapies
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
CA2777066C (en) 2009-10-14 2020-02-18 TheraVasc, LLC Pharmaceutical formulations of nitrite and uses thereof
CA2781295C (en) * 2009-11-20 2018-02-13 Geno Llc Nitric oxide delivery system
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
WO2013026000A1 (en) 2011-08-17 2013-02-21 Board Of Regents, The University Of Texas System Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
ES2741146T3 (es) 2013-02-20 2020-02-10 The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College Formulaciones farmacéuticas de nitrio y sus usos
GB201309092D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201309091D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Dressing system
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
TWI562038B (en) * 2015-07-08 2016-12-11 Wistron Corp Method of detecting touch position and touch apparatus thereof
GB201520990D0 (en) 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
WO2020227367A1 (en) * 2019-05-06 2020-11-12 Pneuma Nitric Oxide, Llc Nitric oxide compositions and topical uses thereof
EP3980032A1 (en) 2019-06-04 2022-04-13 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
GB2599576B (en) 2019-06-04 2023-09-13 Thirty Holdings Ltd Methods and compositions for generating nitric oxide and uses thereof
EP4138795A1 (en) * 2020-04-23 2023-03-01 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
GB2610721B (en) * 2020-04-23 2024-07-31 Thirty Respiratory Ltd Compositions for treating and combatting tuberculosis
WO2024220093A2 (en) * 2023-04-20 2024-10-24 LifeActive, Inc. Transdermal delivery formulations and methods for the manufacture thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
NZ252895A (en) * 1992-06-08 1996-10-28 Pitmy Int Nv Dermatological compositions containing nitrous oxide and at least one essential fatty acid or ester thereof, optionally with other ingredients
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
PL180769B1 (pl) * 1994-02-21 2001-04-30 Univ Aberdeen Postać dawkowana do miejscowego leczenia stanów powodowanych przez drobnoustroje, sposób sterylizacji obiektów i kompozycja sterylizująca
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
JP3002772B2 (ja) * 1996-05-15 2000-01-24 マルホ株式会社 貼付剤及びその製造法
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US7404990B2 (en) * 2002-11-14 2008-07-29 Air Products And Chemicals, Inc. Non-thermal process for forming porous low dielectric constant films
US7056840B2 (en) * 2003-09-30 2006-06-06 International Business Machines Corp. Direct photo-patterning of nanoporous organosilicates, and method of use

Also Published As

Publication number Publication date
WO2000053193A1 (en) 2000-09-14
GB9905425D0 (en) 1999-05-05
EP1161248A1 (en) 2001-12-12
ES2326729T3 (es) 2009-10-19
PT1161248E (pt) 2009-08-05
US20020090401A1 (en) 2002-07-11
EP1161248B1 (en) 2009-05-06
US20150004258A1 (en) 2015-01-01
JP2002538210A (ja) 2002-11-12
US20080226751A1 (en) 2008-09-18
DE60042153D1 (de) 2009-06-18
ATE430573T1 (de) 2009-05-15
JP5084985B2 (ja) 2012-11-28
AU2931500A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
DE60042153D1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
ES2275716T3 (es) Composicion farmaceutica de liberacion transdermica.
EA200101166A1 (ru) Ингибиторы металлопротеаз
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
AU2003297260A1 (en) Fast-disintegrating solid dosage forms being not friable and comprising pullulan
TR200500745T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
SE9701162D0 (sv) New use II
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
TR200101719T2 (tr) Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı
DE69034070D1 (de) Racemisches Huperzin A
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
EE200200087A (et) Kompositsioon hepatotsellulaarse kartsinoomi raviks
ATE232390T1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
AR024907A1 (es) Uso de inhibidores de la produccion y/o accion de la il-18 y composiciones farmaceuticas formuladas con dichos inhibidores para el tratamiento demetastasis de tumores.
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
PA8525801A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
SE0000303D0 (sv) Novel compounds
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12